![Frank Mathias](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 191 230 $ al 31/05/2026
Frank Mathias currently works at Oxford Biomedica Plc, as Chief Executive Officer & Director from 2023, OXB US, Inc., as Chief Executive Officer, August Faller GmbH & Co. KG, as Chairman-Supervisory Board, Vfa Bio, as Chairman, ArcticZymes Technologies ASA, as Chairman from 2024, Seqens SAS, as Director, Rentschler Biopharma SE, as Member-Supervisory Board from 2023, LEUKOCARE AG, as Member-Supervisory Board, Mediatum GmbH, as Member-Supervisory Board, leon-nanodrugs GmbH, as Member-Supervisory Board, and Rentschler Biotechnologie Beteiligungs GmbH, as Member-Supervisory Board.
Dr. Mathias also formerly worked at AMGEN GmbH, as Chief Executive Officer, Dr. Rentschler Holding GmbH & Co. KG, as Chief Executive Officer, Catherex, Inc., as Director, Hoechst AG, as Manager-International Product, MediGene AG, as Member-Executive Board in 2016, Servier Deutschland GmbH, as General Manager, and MediGene AG, as Independent Member-Supervisory Board.
Dr. Mathias received his doctorate degree in 1991 from Université Pierre et Marie Curie.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC 0,02 % | 31/12/2025 | 20.000 ( 0,02 % ) | 169 303 $ | 31/05/2026 |
| 31/12/2024 | 9.000 ( 0,02 % ) | 21 927 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OXFORD BIOMEDICA PLC | Director Ejecutivo | 27/03/2023 |
| ARCTICZYMES TECHNOLOGIES ASA | Presidente | 26/06/2024 |
August Faller GmbH & Co. KG
 August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Presidente | - |
Vfa Bio | Presidente | - |
Rentschler Biotechnologie Beteiligungs GmbH
 Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Director/Miembro de la Junta | - |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Director/Miembro de la Junta | - |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Director/Miembro de la Junta | - |
Mediatum GmbH | Director/Miembro de la Junta | - |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Director/Miembro de la Junta | 31/03/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 17 |
|---|---|
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
ArcticZymes Technologies ASA
 ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Health Technology |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
Dr. Rentschler Holding GmbH & Co. KG
 Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in pharmaceutical research and production | Commercial Services |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seqens SAS
 Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics | Process Industries |
August Faller GmbH & Co. KG
August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Process Industries |
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Health Services |
Servier Deutschland GmbH
 Servier Deutschland GmbH Pharmaceuticals: MajorHealth Technology Engages in research, development and distribution of pharmaceutical products | Health Technology |
Catherex, Inc.
 Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Mediatum GmbH | |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
Rentschler Biotechnologie Beteiligungs GmbH
Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Finance |
Vfa Bio |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
